£520.00

It has never been this cheap. We have no record of a lower price.

£520 today · cheaper than every other day in the last 3 months

US Bone Marrow Autologous Cell Therapies Outlook 2023-2028

View at Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 89 days · 89 data points

Historical
Generating forecast…
£520.00 £494.00 £504.40 £514.80 £525.20 £535.60 £546.00 11 August 2026 02 September 2026 24 September 2026 16 October 2026 07 November 2026
View at Amazon ↗

Price data checked 2 days ago

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 89 days • 1 price levels

Days at Price
89 days 0 22 45 67 89 £520 Days at Price

Price Analysis

Most common price: £520 (89 days, 100.0%)

Price range: £520 - £520

Price levels: 1 different prices over 89 days

Description

This market study provides a detailed outlook for bone marrow autologous cell therapies in the United States from 2023 to 2028. It focuses on latent demand, also known as potential industry earnings (P.I.E.), across the country. The data includes estimates for approximately 12,600 cities, offering a granular view of market opportunities at the local level. By providing the percent share of each city relative to its state and the United States as a whole, this report offers comparative benchmarks for quick analysis. These statistics are designed to assist professionals in developing effective distribution and sales force strategies based on localized demand data.

Key Features

Covers the 2023-2028 outlook for bone marrow autologous cell therapies in the United States.

Provides latent demand estimates in millions of U.S. dollars across 12,600 cities.

Includes potential industry earnings (P.I.E.) data to help identify market opportunities.

Reports percent share for each city compared to its state and the entire United States.

Offers comparative benchmarks to help gauge city performance against others.

Supports the development of data-driven distribution and sales force strategies.

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
26 October 2022
Listed Since
09 November 2022

Similar Products You Might Like

Bone Marrow Autologous Cell Therapies in India Outlook 2023-2028
99% match

Bone Marrow Autologous Cell Therapies in India Outlook 2023-2028

£515.00 06 Nov 2026
The 2023-2028 Outlook for Bone Marrow Autologous Cell Therapies in China
99% match

The 2023-2028 Outlook for Bone Marrow Autologous Cell Therapies in China

£495.00 07 Nov 2026
The 2023-2028 World Outlook for Bone Marrow Autologous Cell Therapies
99% match

The 2023-2028 World Outlook for Bone Marrow Autologous Cell Therapies

Price unavailable
The 2023-2028 Outlook for Bone Marrow Autologous Cell Therapies in Japan
99% match

The 2023-2028 Outlook for Bone Marrow Autologous Cell Therapies in Japan

£495.00 05 Nov 2026
US Bone Marrow Transplant Outlook 2023-2028 Study Report
98% match

US Bone Marrow Transplant Outlook 2023-2028 Study Report

£520.00 05 Nov 2026
Bone Marrow Transplant Outlook in India 2023-2028 Study
98% match

Bone Marrow Transplant Outlook in India 2023-2028 Study

£515.00 06 Nov 2026
The 2026-2031 World Outlook for Bone Marrow Transplantation
98% match

The 2026-2031 World Outlook for Bone Marrow Transplantation

£885.00 07 Nov 2026
The 2023-2028 Outlook for Bone Marrow Transplants in China
98% match

The 2023-2028 Outlook for Bone Marrow Transplants in China

£495.00 26 Aug 2026
Bone Marrow Transplant Outlook 2023-2028 - US Zip Code Study
97% match

Bone Marrow Transplant Outlook 2023-2028 - US Zip Code Study

£490.00 05 Nov 2026
The 2026-2031 World Outlook for Autologous Bone Marrow Transplants
97% match

The 2026-2031 World Outlook for Autologous Bone Marrow Transplants

£885.00 06 Nov 2026
The 2026-2031 World Outlook for Adult Stem Cell Research
97% match

The 2026-2031 World Outlook for Adult Stem Cell Research

£885.00 26 Aug 2026
Stem Cell Products Outlook 2016-2021 - US Market Study
97% match

Stem Cell Products Outlook 2016-2021 - US Market Study

£595.00 02 Sep 2026
US Hematology and Oncology Products Market Outlook 2016-2021
97% match

US Hematology and Oncology Products Market Outlook 2016-2021

£595.00 18 Sep 2026
97% match

Wright ∗long–term∗ Bone Marrow Culture

Wiley

Price unavailable
Bone Marrow Environment Methods and Protocols 2308
97% match

Bone Marrow Environment Methods and Protocols 2308

Humana

£113.94 03 Oct 2026
Erythropoietin Drugs US Outlook 2023-2028 Study Report
97% match

Erythropoietin Drugs US Outlook 2023-2028 Study Report

£520.00 03 Sep 2026
Hematology and Oncology Products in India Outlook 2016-2021
96% match

Hematology and Oncology Products in India Outlook 2016-2021

£595.00 07 Nov 2026
Multiple Myeloma Therapeutics in Africa 2013-2018 Outlook
96% match

Multiple Myeloma Therapeutics in Africa 2013-2018 Outlook

£325.00 03 Sep 2026
Bone Marrow: Clinical Perspectives
96% match

Bone Marrow: Clinical Perspectives

Hayle Medical

£73.66 24 Sep 2026
The 2016-2021 Outlook for Hematology and Oncology Products in Greater China
96% match

The 2016-2021 Outlook for Hematology and Oncology Products in Greater China

£595.00 01 Oct 2026
The 2016-2021 Outlook for Erythropoietins in the United States
96% match

The 2016-2021 Outlook for Erythropoietins in the United States

£595.00 28 Aug 2026
US Cell Culture Media Outlook 2016-2021 - Econometric Study
96% match

US Cell Culture Media Outlook 2016-2021 - Econometric Study

£595.00 26 Aug 2026
World Outlook for T-Cell Therapies 2025-2030 Report
96% match

World Outlook for T-Cell Therapies 2025-2030 Report

£790.00 27 Aug 2026
The 2021-2026 World Outlook for Hematology and Oncology Products
96% match

The 2021-2026 World Outlook for Hematology and Oncology Products

£795.00 05 Nov 2026